Ocrevus Still Top Therapy for Progressive MS Forms, Report Finds

Ocrevus Still Top Therapy for Progressive MS Forms, Report Finds

311459

Ocrevus Still Top Therapy for Progressive MS Forms, Report Finds

Ocrevus (ocrelizumab) continues to be the most commonly prescribed therapy for progressive forms of multiple sclerosis (MS), including primary progressive MS (PPMS) and secondary progressive MS (SPMS), according to an analysis from the market intelligence firm Spherix Global Insights. However, other therapies are “gaining traction” among SPMS patients, the report finds. Most people who are diagnosed with MS will first be diagnosed with relapsing-remitting disease (RRMS), which is characterized by periods of worsening symptoms (relapses)…

You must be logged in to read/download the full post.